niacinamide has been researched along with Chronic Kidney Disease-Mineral and Bone Disorder in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Chronic Kidney Disease-Mineral and Bone Disorder: Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tani, T | 1 |
| Fujiwara, M | 1 |
| Orimo, H | 1 |
| Shimizu, A | 1 |
| Narisawa, S | 1 |
| Pinkerton, AB | 1 |
| Millán, JL | 1 |
| Tsuruoka, S | 1 |
| Ginsberg, C | 1 |
| Ix, JH | 1 |
1 review available for niacinamide and Chronic Kidney Disease-Mineral and Bone Disorder
| Article | Year |
|---|---|
Nicotinamide and phosphate homeostasis in chronic kidney disease.
Topics: Animals; Chronic Kidney Disease-Mineral and Bone Disorder; Homeostasis; Humans; Hyperphosphatemia; N | 2016 |
1 other study available for niacinamide and Chronic Kidney Disease-Mineral and Bone Disorder
| Article | Year |
|---|---|
Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model.
Topics: Alkaline Phosphatase; Animals; Aorta; Aortic Diseases; Chronic Kidney Disease-Mineral and Bone Disor | 2020 |